SpaceX Over, Fed Meeting Done, What’s Next?

Watch on YouTube ↗  |  June 19, 2026 at 20:02  |  32:30  |  1000x Podcast
Speakers
Avi Felman — Principal, GoldenTree Asset Management

Summary

Avi Felman hosts a solo Juneteenth stream covering market reactions to the Fed and SpaceX, then outlines specific bullish calls on semiconductors, Robinhood, ARK Genomic ETF, and uranium. He also argues for avoiding emerging markets, gold, Bitcoin, and commodities due to US dollar strength, flags the Iran deal as a future risk for oil and equities, and introduces AI biotech and nuclear energy as the next two megatrends.

  • Market shrugged off hawkish Fed and rate hike repricing, entering a Goldilocks period with limited summer downside.
  • Mag7 equities lag semiconductors because their equity and debt issuance flows into chipmakers like Intel, SanDisk, and Micron.
  • Robinhood (HOOD) is a preferred long thanks to surging platform assets, gold subscribers, and bullish cost-cutting.
  • Workforce layoffs are reframed as bullish capital reallocation rather than bearish.
  • Persistent consumer inflation and struggles of the bottom half pose a long-term risk to market appreciation.
  • US exceptionalism and a strong dollar are headwinds for gold, Bitcoin, and commodities; emerging markets are also avoided.
  • The Iran agreement is a win for Iran and an eventual flashpoint that could spike oil and tumble equities after midterms.
  • AI biotech is a new megatrend fueled by FDA leniency and genuine AI-driven drug discovery; Avi bought ARK Genomic ETF (ARKG) and is watching Insilico Medicine.
  • A nuclear revolution in the US over the next 3–5 years makes the uranium ETF URA a high-conviction 3–5x long.
Ideas
Avi Felman Principal, GoldenTree Asset Management 2:55
Mag7 capex fuels semiconductor outperformance
Mag7 companies are selling equity and raising debt to fund massive capex for AI data centers, which directly benefits the semiconductor companies they buy from; Intel just signed a deal with Apple, and the entire semiconductor complex is continuously rampaging higher. This dynamic will persist through the summer.
Avi Felman Principal, GoldenTree Asset Management 4:50
Goldilocks period drives US equities higher
Buy SPY as broad US equities enter a Goldilocks summer setup: markets shrugged off hawkish Fed/rate-hike pricing, Iran/oil fears, and earnings worries, and slowing summer news flow could support a rally into August.
Avi Felman Principal, GoldenTree Asset Management 5:49
HOOD growth reaccelerates, layoffs are bullish
Robinhood (HOOD) is performing very well: platform assets up 50% YoY to ~$400B, gold subscribers up 36% in Q1, and they are rolling out crypto trading to all users. The recent 10% workforce cut is bullish because the savings get reallocated to growth areas and share buybacks. HOOD is a better play than Hyperliquid, which is being held back by the crypto complex.
Avi Felman Principal, GoldenTree Asset Management 14:50
Avoid emerging markets, US exceptionalism dominates
The thesis that emerging markets would dominate in 2026 has completely failed; only Korea performed because of its semiconductor industry, while true AI-driven innovation remains concentrated in the United States. This makes EM an unattractive destination for capital.
Avi Felman Principal, GoldenTree Asset Management 15:00
Strong dollar hits gold, Bitcoin, commodities
US exceptionalism is strengthening the dollar, which is unambiguously negative for gold, Bitcoin, and commodities in general. Additionally, Michael Saylor's STRC problems and the structural unwind in Bitcoin reinforce that one should not be touching Bitcoin right now.
Avi Felman Principal, GoldenTree Asset Management 16:01
Iran flare-up risk spikes oil, hits equities
The Iran deal is a win for Iran and an untenable agreement that will likely lead to future conflict. With the administration focused on keeping the situation calm through the midterms, a flare-up could occur after the midterms, causing a spike in oil prices and a tumble in equity markets. This is a setup to monitor closely.
Avi Felman Principal, GoldenTree Asset Management 18:46
AI biotech megatrend, buy ARKG
AI is finally being applied to physical products and drug discovery, not just software. The FDA under RFK is becoming much more accommodating, as shown by the full U-turn on gene therapy. Avi bought ARKG (ARK Genomic Revolution ETF) with 3% of his portfolio and plans to increase exposure to genomics and biotech as this megatrend plays out.
Avi Felman Principal, GoldenTree Asset Management 21:30
Monitor Insilico Medicine
Insilico Medicine is a pure-play AI drug discovery company based in Boston but trading on the Hong Kong stock exchange. With AI revolutionizing biotech and the FDA becoming more lenient, this company is a compelling candidate to watch while he conducts deeper research.
Avi Felman Principal, GoldenTree Asset Management 25:11
Nuclear renaissance, buy uranium ETF URA
A nuclear revolution is coming in the US over the next 3–5 years driven by the Trump administration and new efficient reactor companies. While uranium commodity prices may not surge because supply can be ramped, the companies and ETFs will see massive revenue growth. URA is well off its highs and could deliver a 3–5x return.
Up Next

This 1000x Podcast video, published June 19, 2026, features Avi Felman discussing INTC, MU, SNDK, SPY, HOOD, EEM, GLD, DBC, BTC, WTI, ARKG, Insilico Medicine, URA. 9 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Avi Felman  · Tickers: INTC, MU, SNDK, SPY, HOOD, EEM, GLD, DBC, BTC, WTI, ARKG, Insilico Medicine, URA